Abstract LB041: THOR-707 (SAR444245), a novel not-alpha IL-2 as monotherapy and in combination with pembrolizumab in advanced/metastatic solid tumors: Interim results from HAMMER, an open-label, multicenter phase 1/2 Study
暂无分享,去创建一个
F. Janku | J. Bendell | M. Milla | G. Falchook | H. Gan | G. Abbadessa | N. Marina | A. Azad | T. Meniawy | C. Chee | Judy S. Wang | T. Tan | Lina Ma | R. Abdul-Karim | J. Mooney